WFDC8
gene geneOn this page
Also known as dJ461P17.1WAP8
Summary
WFDC8 (WAP four-disulfide core domain 8, HGNC:16163) is a protein-coding gene on chromosome 20q13.12, encoding WAP four-disulfide core domain protein 8 (Q8IUA0).
This gene encodes a member of the WAP-type four-disulfide core (WFDC) domain family. The WFDC domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor. The encoded protein contains a Kunitz-inhibitor domain, in addition to three WFDC domains. Most WFDC genes are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the telomeric cluster. Two alternatively spliced transcript variants have been found for this gene, and they encode the same protein.
Source: NCBI Gene 90199 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_130896
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16163 |
| Approved symbol | WFDC8 |
| Name | WAP four-disulfide core domain 8 |
| Location | 20q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ461P17.1, WAP8 |
| Ensembl gene | ENSG00000158901 |
| Ensembl biotype | protein_coding |
| Entrez | 90199 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000289953, ENST00000357199
RefSeq mRNA: 2 — MANE Select: NM_130896
NM_130896, NM_181510
CCDS: CCDS13361
Canonical transcript exons
ENST00000289953 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001041886 | 45558852 | 45558992 |
| ENSE00001041894 | 45555701 | 45555868 |
| ENSE00001041913 | 45553136 | 45553276 |
| ENSE00001125155 | 45562110 | 45562219 |
| ENSE00001321878 | 45551762 | 45552165 |
| ENSE00003899398 | 45579222 | 45579284 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 99.23.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1428 / max 228.1490, expressed in 7 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187461 | 0.0659 | 4 |
| 187459 | 0.0187 | 2 |
| 187462 | 0.0180 | 2 |
| 187460 | 0.0138 | 3 |
| 187463 | 0.0124 | 1 |
| 187458 | 0.0071 | 1 |
| 209143 | 0.0070 | 1 |
Top tissues by expression
197 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 99.23 | gold quality |
| cauda epididymis | UBERON:0004360 | 91.65 | gold quality |
| sperm | CL:0000019 | 77.41 | gold quality |
| caput epididymis | UBERON:0004358 | 68.38 | gold quality |
| oocyte | CL:0000023 | 66.72 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 64.71 | gold quality |
| endometrium epithelium | UBERON:0004811 | 64.56 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 56.71 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 55.97 | gold quality |
| mammary duct | UBERON:0001765 | 55.89 | gold quality |
| buccal mucosa cell | CL:0002336 | 55.80 | gold quality |
| vena cava | UBERON:0004087 | 54.95 | gold quality |
| skin of hip | UBERON:0001554 | 53.84 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 53.51 | gold quality |
| upper leg skin | UBERON:0004262 | 53.45 | silver quality |
| paraflocculus | UBERON:0005351 | 52.36 | gold quality |
| quadriceps femoris | UBERON:0001377 | 51.55 | gold quality |
| thymus | UBERON:0002370 | 51.31 | gold quality |
| seminal vesicle | UBERON:0000998 | 51.25 | gold quality |
| vastus lateralis | UBERON:0001379 | 51.20 | gold quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 50.18 | gold quality |
| cerebellar vermis | UBERON:0004720 | 49.25 | gold quality |
| adult organism | UBERON:0007023 | 47.69 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 46.19 | gold quality |
| endometrium | UBERON:0001295 | 46.15 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 45.73 | gold quality |
| ventral tegmental area | UBERON:0002691 | 45.61 | gold quality |
| biceps brachii | UBERON:0001507 | 45.02 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-38 | yes | 899.12 |
| E-ANND-3 | yes | 3.93 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting WFDC8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-3682-3P | 99.58 | 67.63 | 865 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-580-5P | 99.28 | 70.94 | 1776 |
| HSA-MIR-3973 | 99.20 | 69.19 | 1990 |
| HSA-MIR-8060 | 98.61 | 66.93 | 1187 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-1245B-3P | 98.01 | 68.91 | 1387 |
| HSA-MIR-4670-3P | 97.37 | 68.35 | 1378 |
Literature-anchored findings (GeneRIF, showing 1)
- We propose that the evolution of WFDC8 and SPINT4 has been shaped by complex selective scenarios due to the interdependence of variant fitness and ecological variables. (PMID:21536719)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spint1b | ENSDARG00000012467 |
| danio_rerio | lrp11 | ENSDARG00000034076 |
| danio_rerio | wfikkn1 | ENSDARG00000101364 |
| danio_rerio | spint1a | ENSDARG00000102332 |
| mus_musculus | Wfdc8 | ENSMUSG00000070533 |
| rattus_norvegicus | Wfdc8 | ENSRNOG00000014771 |
| drosophila_melanogaster | CG7565 | FBGN0035833 |
| caenorhabditis_elegans | WBGENE00008449 | |
| caenorhabditis_elegans | WBGENE00009386 | |
| caenorhabditis_elegans | WBGENE00010792 | |
| caenorhabditis_elegans | WBGENE00015355 | |
| caenorhabditis_elegans | WBGENE00021939 |
Paralogs (13): TFPI (ENSG00000003436), EPPIN (ENSG00000101448), TFPI2 (ENSG00000105825), AMBP (ENSG00000106927), LRP11 (ENSG00000120256), WFIKKN1 (ENSG00000127578), KIAA0319 (ENSG00000137261), KIAA0319L (ENSG00000142687), SPINT4 (ENSG00000149651), SPINT1 (ENSG00000166145), SPINT2 (ENSG00000167642), WFIKKN2 (ENSG00000173714), WFDC6 (ENSG00000243543)
Protein
Protein identifiers
WAP four-disulfide core domain protein 8 — Q8IUA0 (reviewed: Q8IUA0)
Alternative names: Putative protease inhibitor WAP8
All UniProt accessions (2): Q8IUA0, A0A140VK68
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Tissue specificity. Expressed ubiquitously, the highest levels are found in the epididymis followed by testis and trachea.
RefSeq proteins (2): NP_570966, NP_852611 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002223 | Kunitz_BPTI | Domain |
| IPR008197 | WAP_dom | Domain |
| IPR020901 | Prtase_inh_Kunz-CS | Conserved_site |
| IPR036645 | Elafin-like_sf | Homologous_superfamily |
| IPR036880 | Kunitz_BPTI_sf | Homologous_superfamily |
Pfam: PF00014, PF00095
UniProt features (23 total): disulfide bond 15, domain 4, sequence variant 2, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IUA0-F1 | 86.80 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (15): 95–145, 104–128, 120–141, 154–182, 165–186, 169–181, 175–190, 201–229, 208–232, 216–228, 222–236, 51–79, 58–83, 66–78, 72–87
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 32 (showing top):
GOMF_PEPTIDASE_REGULATOR_ACTIVITY, GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY, JAK2_DN.V1_UP, HMGA1_TARGET_GENES, MIR182_5P, MIR580_5P, MIR5197_3P, MIR222_5P, MIR3129_5P, MIR199A_3P_MIR199B_3P, MIR5089_5P, MIR3682_3P
GO Biological Process (0):
GO Molecular Function (2): serine-type endopeptidase inhibitor activity (GO:0004867), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| serine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
432 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| WFDC8 | SPINT4 | Q6UDR6 | 809 |
| WFDC8 | WFDC6 | Q9BQY6 | 804 |
| WFDC8 | WFDC9 | Q8NEX5 | 669 |
| WFDC8 | WFDC10A | Q9H1F0 | 636 |
| WFDC8 | SEMG1 | P04279 | 607 |
| WFDC8 | SEMG2 | Q02383 | 582 |
| WFDC8 | PATE1 | Q8WXA2 | 547 |
| WFDC8 | WFDC3 | Q8IUB2 | 544 |
| WFDC8 | SPINK13 | Q1W4C9 | 519 |
| WFDC8 | EDDM3B | P56851 | 517 |
| WFDC8 | DEFB134 | Q4QY38 | 506 |
| WFDC8 | WFDC5 | Q8TCV5 | 506 |
| WFDC8 | WFDC11 | Q8NEX6 | 491 |
| WFDC8 | DEFB131A | P59861 | 478 |
| WFDC8 | PI3 | P19957 | 474 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| WFDC8 | ACTA2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): SYCE2 (Affinity Capture-MS), ACTA2 (Affinity Capture-MS), APBB2 (Affinity Capture-MS), WFDC8 (Reconstituted Complex)
ESM2 similar proteins: A4K2M5, A4K2N9, A4K2P7, A4K2Q7, A4K2R4, A4K2S3, A4K2T2, A4K2U0, A4K2V3, A4K2W7, A4K2X5, A4K2Y3, A7X4K1, A7X4M7, B5G6G7, B5G6G8, B5G6G9, B5G6H0, B5G6H1, B5G6H2, B5G6H3, B5G6H4, B5G6H5, B5KGY9, B5L5M9, B5L5N1, B5L5N2, B5L5N3, B5L5N4, B5L5N6, B5L5P0, B5L5P2, B5L5P3, B5L5P4, B5L5P5, B5L5P6, B5L5P7, B5L5P8, B5L5P9, P01174
Diamond homologs: A4K2M5, A4K2N9, A4K2P7, A4K2Q7, A4K2R4, A4K2S3, A4K2T2, A4K2U0, A4K2U1, A4K2V3, A4K2W7, A4K2X5, A4K2X6, A4K2Y3, P03973, Q8IUA0, Q8TCV5, A0A6P8HC43, A7X3V7, A8Y7N9, B1B5I8, B2G331, B2ZBB6, B5M0W4, B6ZIW0, C0HJF3, C0HK74, C0HLB2, C0HMC7, C1IBY4, C1IC51, C1IC52, C8YJ94, C8YJ95, D4A2Z2, D8KY58, F5GTK6, F6ULY1, I2G9B4, O35536
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
907 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:45562108:A:AC | donor_gain | 1.0000 |
| 20:45562109:C:CC | donor_gain | 1.0000 |
| 20:45579220:ACCCT:A | donor_gain | 1.0000 |
| 20:45579221:CCCTC:C | donor_gain | 1.0000 |
| 20:45562101:TGAAC:T | donor_loss | 0.9900 |
| 20:45562102:GAAC:G | donor_loss | 0.9900 |
| 20:45562103:AACTC:A | donor_loss | 0.9900 |
| 20:45562104:ACTCA:A | donor_loss | 0.9900 |
| 20:45562105:C:G | donor_loss | 0.9900 |
| 20:45562106:T:TA | donor_loss | 0.9900 |
| 20:45562107:CAC:C | donor_loss | 0.9900 |
| 20:45562108:A:C | donor_loss | 0.9900 |
| 20:45579220:AC:A | donor_gain | 0.9900 |
| 20:45579221:CC:C | donor_gain | 0.9900 |
| 20:45579224:T:A | donor_gain | 0.9900 |
| 20:45579258:C:A | donor_gain | 0.9900 |
| 20:45562109:CGT:C | donor_gain | 0.9800 |
| 20:45562218:GCC:G | acceptor_loss | 0.9800 |
| 20:45579221:CCCT:C | donor_gain | 0.9800 |
| 20:45562109:CG:C | donor_gain | 0.9700 |
| 20:45553277:C:CC | acceptor_gain | 0.9600 |
| 20:45562216:GTGC:G | acceptor_gain | 0.9600 |
| 20:45562217:TGC:T | acceptor_gain | 0.9600 |
| 20:45562220:C:CC | acceptor_gain | 0.9600 |
| 20:45579217:CTCAC:C | donor_loss | 0.9600 |
| 20:45579218:TCA:T | donor_loss | 0.9600 |
| 20:45579219:CAC:C | donor_loss | 0.9600 |
| 20:45579220:A:AG | donor_loss | 0.9600 |
| 20:45579221:C:A | donor_loss | 0.9600 |
| 20:45579228:T:TA | donor_gain | 0.9600 |
AlphaMissense
1616 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:45555742:A:C | F135C | 0.993 |
| 20:45555741:G:C | F135L | 0.990 |
| 20:45555741:G:T | F135L | 0.990 |
| 20:45555743:A:G | F135L | 0.990 |
| 20:45555787:C:G | C120S | 0.984 |
| 20:45555788:A:T | C120S | 0.984 |
| 20:45553198:C:G | C175S | 0.983 |
| 20:45553199:A:T | C175S | 0.983 |
| 20:45552105:C:G | C216S | 0.982 |
| 20:45552106:A:T | C216S | 0.982 |
| 20:45553261:C:G | C154S | 0.982 |
| 20:45553262:A:T | C154S | 0.982 |
| 20:45555807:A:C | F113L | 0.982 |
| 20:45555807:A:T | F113L | 0.982 |
| 20:45555809:A:G | F113L | 0.982 |
| 20:45555724:C:G | C141S | 0.980 |
| 20:45555725:A:T | C141S | 0.980 |
| 20:45555742:A:G | F135S | 0.979 |
| 20:45552087:C:G | C222S | 0.978 |
| 20:45552088:A:T | C222S | 0.978 |
| 20:45555813:C:A | W111C | 0.978 |
| 20:45555813:C:G | W111C | 0.978 |
| 20:45553180:C:G | C181S | 0.977 |
| 20:45553181:A:T | C181S | 0.977 |
| 20:45553216:C:G | C169S | 0.977 |
| 20:45553217:A:T | C169S | 0.977 |
| 20:45555747:G:C | N133K | 0.976 |
| 20:45555747:G:T | N133K | 0.976 |
| 20:45555862:C:G | C95S | 0.975 |
| 20:45555863:A:T | C95S | 0.975 |
dbSNP variants (sampled 300 via entrez): RS1000202876 (20:45552584 C>A), RS1000206760 (20:45577020 C>T), RS1000253746 (20:45552943 G>C), RS1000431424 (20:45570400 A>C), RS1000841040 (20:45558508 T>C), RS1000848617 (20:45570509 G>C), RS1000850238 (20:45563449 G>A,T), RS1001042485 (20:45553272 C>G,T), RS1001125790 (20:45556852 T>A), RS1001144081 (20:45576794 T>G), RS1001168109 (20:45571897 T>C), RS1001198082 (20:45577111 A>T), RS1001426601 (20:45576554 C>A), RS1001435498 (20:45559359 G>A), RS1001489810 (20:45578158 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| perfluorooctanoic acid | increases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.